• <tr id="yyy80"></tr>
  • <sup id="yyy80"></sup>
  • <tfoot id="yyy80"><noscript id="yyy80"></noscript></tfoot>
  • 99热精品在线国产_美女午夜性视频免费_国产精品国产高清国产av_av欧美777_自拍偷自拍亚洲精品老妇_亚洲熟女精品中文字幕_www日本黄色视频网_国产精品野战在线观看 ?

    14 Hematopoietic System

    2015-03-22 06:06:40
    關(guān)鍵詞:楊力

    14 Hematopoietic System

    2015231 Clinical observations of lenalidomide combination chemotherapy for relapsing or refractory multiple myeloma.LI Xin(李新),et al.Dept Hematol,Beijing Chaoyang Hosp,Capital Med Univ,Beijing 100043.Natl Med J China 2015;95(10):745-748.

    Objective To explore the clinical efficacies and toxicities of lenalidomide combination chemotherapy in the treatment of relapsing or refractory multiple myeloma (MM)patients.Methods A total of 14 MM patients were recruited to receive lenalidomide combination chemotherapy in Beijing Chaoyang hospital from June 2013 to October 2014.Lenalidomide 25 mg was taken orally daily or every alternate day for 21 days and resting for 7 days.The regiments were RD(lenalidomide and dexamethasone,n=6),RCD(lenalidomide,ifosfamide and dexamethasone,n=4),RDD(lenalidomide,liposomal doxorubicinand dexamethasone,n=1),PRD( lenalido-mide,velcade and dexamethasone,n=1)and R+ DECP(lenalidomide,cisplatin,etoposide,ifosfamide and dexamethasone,n=2).Results Among them,two patients died during the first cycle of lenalidomide.Ten patients finished 2 cycles of treatment and 2 patients attained near complete remission or complete remission (nCR/CR),6 partial remission(PR)and 2 stable disease(SD)with an overall response rate(ORR)of 8/10. Ten patients finished 3 cycles of treatment and 3 attained CR,5 PR and 2 SD.Nine patients finished 4 cycles of treatment and 3 attained CR,5 PR and 1 progressive disease(PD).Six patients finished 5 cycles of treatment and 1 attained CR,3 PR and 2 PD.Three patients finished 6 cycles of treatment and 1 attained CR,1 PR and 1 PD.And the most common adverse reactions were fatigue,loss of appetite and hypocytosis.Six patients died.Conclusion The lenalidomide combination chemotherapy is both efficacious and safe in the treatment of relapsing or refractory MM.

    (Authors)

    2015232 Study on the molecular mechanisms of a novel large deletion of FⅩⅢA mRNA in a new hereditary factorⅩⅢdeficiency.MA Qiuling(馬秋玲),et al.Dept Biochem&Molec Biol,Hainan Med Coll,Haikou 571101.Chin J Hematol 2015;36(2):131-134.

    Objective To investigate the mechanisms of Del-CD11-279 of factorⅩⅢsubunit A mRNA in the pathogenesis of hereditary factorⅩⅢdeficiency.Methods The recombinant plasmids containing pET-22b(+)/FⅩⅢA of normal subject and proband's mother and pET-22b (+)/FⅩⅢA-Del of the proband were constructed and transformed into E.coli BL21.Expressing protein was analyzed by the SDS-PAGE and purified by Ni-NTA resin.Purified proteins were detected by the Western-blot. The activity of purified protein was detected by the incorporation test with EZ-LinkTM5-(Biotinamide)Pentylamine.Results The recombinant plasmids containing pET-22b(+)/FⅩⅢA and pET-22b(+)FⅩⅢA-Del which constructed and identified successfully by enzyme digestion and PCR,were transformed into E.coli BL21 and efficiently expressed by IPTG induction.The molecular weights of expressing proteins were 83 200 and 51 900 by the SDS-PAGE.Expressing proteins were purified by Ni-NTA resin,and were proven to be human FⅩⅢA proteins by Western-blot.Purified protein activity of proband's mother and proband was 95.87%and 0 of the purified FⅩⅢA protein activity from the normal subjects,respectively.Conclusion DelCD11-279 of FⅩⅢA mRNA which encoding a 464 amino acids of inactive FⅩⅢA protein is one of the molecular mechanisms resulting in FⅩⅢdeficiency in the patient.

    (Authors)

    2015233 Potential relationship and clinical significance of miRNAs and Th17 related cytokines in patients with multiple myeloma.LI Yanjie(李艷杰),et al.Dept Hematol,Affil Hosp,Xuzhou Med Coll,Xuzhou 221002.Chin J Hematol 2015;36(2):125-130.

    Objective To explore the expression and significance of miRNAs and Th17 related cytokines in patients with multiple myeloma(MM).Methods A total of 27 MM patients and 8 healthy controls were enrolled in this study.The expression of miR-15a/16,miR-34a,miR-194-2-192 cluster and miR-181a/b in bone marrow were detected by real-time quantitative PCR(qRT-PCR).Enzyme-linked immunosorbent assay(ELISA)was used to determine the levels of Th17 related cytokines interleukin-17(IL-17),IL-21,IL-22,IL-23 and IL-27 in peripheral blood plasma.The role of miRNAs and Th17 related cytokines was analyzed in the development of MM. Results The expression of miR-15a/16,miR-34a,miR-194-2-192 cluster in MM patients were significantly lower than those of the healthy controls,while miR-181a/b were exactly the reverse(P<0.05).The levels of IL-17,IL-21 and IL-27 were up-regulated in MM patients compared to healthy controls while IL-22 was down-regulated(P<0.05).There was no significant difference of IL-23 between the two groups.The levels of miRNAs and Th17 related cytokines had associated with ISS but not with some clinical parameters(such as gender,age,disease classification).Higher expression of IL-17,IL-21,IL-23,IL-27, miR-181a/b and lower expression of miR-15a/16,miR-34a,miR-194 and IL-22 were observed in the end stage than the early stage of MM patients(P<0.05).There was a significant correlation between miRNAs and Th17 elated cytokines.Conclusion Up-regulated IL-17,IL-21 and IL-27 may potentially down-regulate the expression of several miRNAs in MM patients. Establishment of the relationship may be useful for understanding the pathogenesis of MM and for clinical diagnosis of the disease.

    (Authors)

    2015234 ALK gene fusion associated non-small cell lung cancer:automated immunostainer detection and clinicopathologic perspectives.SHEN Qin(沈勤),et al.Dept Pathol,Jinling Hosp,South Med Univ,Nanjing 210002.Chin J Pathol 2015;44(3):164-169.

    Objective To explore the automated immunostainer screening anaplastic lymphoma kinase(ALK)gene fusion non-small cell lung cancer(NSCLC)and clinicopathological characteristics of the molecular subtype lung cancers.Methods Five hundred and sixty-six cases of NSCLC were collected over a 16 month period.The test for ALK was performed by Ventana automated immunostainer with anti-ALK D5F3.The histological features,treatment and outcome of patients were assessed.Results Thirty-eight cases(6.75,38/566)of NSCLC showed ALK gene fusion.The frequency of ALK gene fusion was higher in male(7.1%,25/350)than that in female (6.0%,13/216)patients,but not achieving statistical significance(χ2=0.270,P=0.604).ALK+NSCLC was more significantly frequent in patients≤60 years(9.9%,28/282)than>60 years(3.5%,10/284)of age.Histologically,the ALK+NSCLCs were mostly adenocarcinoma(81.6%,31/38),among which eighteen cases were solid predominant subtype with mucin production;nine cases were acinar predominant subtype;one case was papillary predominant subtype and three cases were invasive mucinous adenocarcinoma.The ALK+non-adenocarcinoma included three cases of squamous cell carcinoma,three cases of adenosquamous carcinoma and one case of pleomorphic carcinoma.Among the ALK+ NSCLC patients,the number of non/light cigarette smokers(86.8%,33/38)was more than that of heavy smokers.Twenty-nine cases were stagesⅢ andⅣ;twentynine cases showed lymph node metastasis;twenty cases showed metastases mostly to brain and bone;and one case showed EGFR gene mutation coexisting with ALK gene fusion.Twelve of fifteen patients received crizotinib therapy and remained stable.Conclusion NSCLC with ALK gene rearrangement shows distinctive clinical and histological features.Ventana-IHC may be a feasible and valid technique for detection of ALK rearrangement in NSCLC.

    (Authors)

    2015235 Clinical analysis of newly diagnosed multiple myeloma patients with renal dysfunction.ZHU Wanqiu(朱婉秋),et al.Beijing Chaoyang Hosp,Capital Med Univ,Beijing 100020.Natl Med J China 2015;95(10):741-744.

    Objective To explore the clinical features and prognostic factors of newly diagnosed multiple myeloma patients with renal insufficiency(MM-RI).Methods The clinical features,survival rates and prognostic factors were retrospectively analyzed for 897 newly diagnosed multiple myeloma(MM)patients at three hospitals from January 1,2010 to June 30,2012.Results Among them,there were 177 cases(19.7%)of MM-RI patients.There were 125 males and 52 females with an average age of 59 years.And 28.2%(50/177)were over 65 years.The types were 17.2%(30/174)of immunoglobulin(Ig)D-λ and 27.6%(48/174)of light chain isotype.And the stages were 94.9%of DS stageⅢ(167/176)and ISS stageⅢ(166/175).Compared with MM patients with normal renal function(MM-RN),MMRI group had a higher proportion of patients with IgD-λ and light chain isotype,more patients of DS and ISS stageⅢ;elevated bone marrow plasma cells,white blood cells and uric acid;lower hemoglobin and platelet (all P<0.05).After a median follow-up period of 24 (2-114)months,the median progression-free survival (PFS)was 28.0 months for MM-RI patients and 29.0 months for MM-RN patients.And the difference was not statistically significant(P=0.457) .The estimated medi-an overall survival(OS)was 44.0 months for MM-RI patients and 59.2 months for MM-RN patients.And the difference was statistically significant(P=0.033).Logrank univariate analysis showed that age,LDH,β2-MG,first-line treatment with or without bortezomib and previous transplantation or not were independent prognostic factors of MM patients.Conclusion MM-RI and MM-RN patients have different clinical features.Age,LDH,β2-MG,first-line treatment with or without bortezomib and previous transplantation or not are independent prognostic factors for newly diagnosed MM patients.

    (Authors)

    2015236 Clinical and cytogenetic characteristics of myeloma patients with overall survival less than 24 months.ZHANG Junling(張俊玲),et al.Dept Hematol,PUMC&CAMS,Beijing 100730.Natl Med J China 2015;95(10):736-740.

    Objective To explore the clinical characteristics of multiple myeloma(MM)patients with overall survival (OS)less than 24 months so as to stratify high-risk population.Methods A total of 177 newly diagnosed MM inpatients were recruited from July 2008 to July 2012. Clinical parameters at diagnosis of international staging system(ISS),lactic dehydrogenase(LDH),serum calcium,extramedullary involvement and amyloidosis were collected and cytogenetic abnormalities were detected by fluorescence in situ hybridization(FISH).Response and death were recorded as endpoints.Otherwise the followup period was over 24 months.Results And 73 patients dying within 24 months were classified into high-risk group while another 104 survivors for over 24 months into control group.Age and gender at baseline were comparable.However,OS of high-risk group was only 8 months while it was not attained during a median follow up of 38 months in control group(P<0.001).The most common cause of death was progressive disease in both groups. The pre-treatment percentages of the following parameters were significantly higher in high-risk group,including ISS stageⅢ[76.71%(56/73)vs 50.00%(52/104),P=0.002],renal dysfunction[47.95%(35/73)vs 31. 73%(33/140),P=0.029],elevated LDH[20.55%(15/73)vs 7.69%(8/104),P=0.015]and plasma cell leukemia[PCL,5.48%(4/73)vs 0(0/104),P= 0.016].Conversely,extramedullary involvement,plasmacytoma,amyloidosis and hypercalcemia were similar. Despite comparable chemotherapeutic regimens,the rate of deep response,including complete response(CR)and very good partial response(VGPR),was significant lower in high-risk group than that in control group[12.33% (9/73)vs 53.85%(56/104),P<0.001].Overall response rates[ORR,i.e.CR+VGPR+partial response (PR)]were markedly different[38.36%(28/73)vs 86.54%(90/104),P<0.001].Univariate analysis of cytogenetic abnormalities indicated a higher proportion of 1q21 amplification in high-risk group[35.62%(26/73)vs 25.15%(22/104),P=0.033].Multivariate Logistic regression revealed that ISS,LDH and primary response worse than PR independently affected early death (P=0.046,0.005,<0.001).Conclusion MM patients with OS less than 24 months have distinct clinical characteristics.And aggressive regimens are needed to improve the outcomes of high-risk population.

    (Authors)

    2015237 Effect of chronic graft versus host disease on relapse and survival in patients with acute myeloid leukemia.ZHAO Xiaoli(趙小利),et al.Dept Hematol,Chin PLA General Hosp,Beijing 100853.Chin J Hematol 2015;36(2):116-120.

    Objective To explore the influence of relapse and survival by chronic graft versus host disease(cGVHD)in patients with acute myeloid leukemia(AML)after allogeneichematopoieticsstemcelltransplantation(allo-HSCT).Methods Fifty-five AML patients received allo-HSCT were retrospectively reviewed.Relapse rate and overall survival(OS)were analyzed according to cGVHD. Results cGVHD significantly decreased the relapse rate of AML patients after transplantation within 2 years when compared with those without cGVHD(8.7%vs 38.6%,P=0.019),however,cGVHD had no effect on the long-term relapse rate(22.8%vs 5.9%,P=0.217). cGVHD had no effect on OS within 2 years(78.3%vs 61.0%,P=0.155) but could decrease the rate of long-term survival(63.7%vs100%,P=0.01).cGVHD also could reduce the rate of relapse(8.3%vs 46.2%,P=0.044)and enhanced the rate of survival(83.3% vs 47.2%,P=0.045)in patients with high risk AML after allo-HSCT in 2 years,while it had no effect on the relapse rate and OS in patients with low and intermediated risk AML in early and late phase.Moreover,compared with the rate of relapse(38.6%)in patients without cGVHD,the rate of relapse were lower in patients with limited cGVHD and intensive cGVHD(27.3%and 31.3%,respectively)but the long-term survival was significantly lower(53.3%,P=0.001)in those patients with intensive cGVHD after all-HSCT.Conclusion The benefit effect of cGVHD mainly took place within 2 years after allo-HSCT in AML patients especially in those with high risk,while in late phase after allo-HSCT,cGVHD especially intensive cGVHD had an effect on reducing long-term survival.

    (Authors)

    2015238 Effect of ERK1/2 inhibitor AZD8330 on human Burkitt's lymphoma cell line Raji cells and its mechanism.FENG Ke(馮可),et al.Dept Hematol,AffilCancerHosp, ZhengzhouUniv, Zhengzhou 450008.Chin J Hematol 2015;36(2):148-152.

    Objective To investigate the effect of ERK1/2 inhibitor AZD8330 on human Burkitt's lymphoma cell line Raji cells and its mechanism.Methods Raji cells were treated with different concentrations of AZD8330.CCK-8 was used to detect the cell viability.The apoptosis rate of Raji cells was detected by flow cytometry using Annexin Ⅴ/PI-staining.Real-time PCR was used to assess the expression of Bcl-2,Bcl-x1,caspase-3andVEGF genes.The protein expression level of Bcl-2,Bcl-x1,caspase-3 and p-ERK1/2 was tested with Western blot. Results The cell survival rate decreased to(62.09± 0.86)%,(50.06±1.33)%and(39.13±2.34)5 respectively after cells were treated with AZD8330 at 1.00 μmol/L in vitro for 24 h,48 h and 72 h,and statistically significant differences were observed in groups with different time of treatment(P<0.05).Apoptosis of cells treated with AZD8330 at 0.10,1.00,10.00 μmol/L in vitro for 24 h,48 h and 72 h was analyzed,and the statistically significant differences were observed in groups of different time and concentration treatment(P<0.05). AZD8330 induced Raji cell apoptosis and upregulated expression of Bcl-2,Bcl-x1,VEFG and decreased the expression of caspase-3 in a dose and time dependent manner,and statistically significant differences were observed in groups of different time and concentration treatment(P<0.05).At the same time,the Bcl-2,Bcl-x1 and p-ERK1/2 proteins expression was suppressed obviously,but the expression of caspase-3 protein increased. Conclusion AZD8330 induces cell apoptosis by downregulating the activation of ERK1/2 signal transduction pathway in Burkitt's lymphoma cell line Raji cells in a dose and time dependent manner.

    (Authors)

    2015239 Effect of ursolic acid on proliferation of T lymphoma cell lines Hut-78 cells and its mechanism. YANG Li(楊力),et al.Dept Hematol,1st Affil Hosp,Soochow Univ,Suzhou 215006.Chin J Hematol 2015;36(2):153-157.

    Objective To investigate the effects of ursolic acid on T cell lymphoma cell lines-Hut-78 cells and its mechanism.Methods Inhibition of Hut-78 cells proliferation by ursolic acid at different concentration(10,20,40 and 80 μmol/L)for different incubation time(4,12,24,48 and 72 h)was examined by MTT method,and early apoptosis by flow cytometry.The protein expressions of p65,p50,p52 and p100,and caspase-8,caspase-3 and caspase-9 were detected by Western blot.VEGF and COX-2 mRNA expressions were measured by reverse transcription polymerase chain reaction(RT-PCR).Results It was showed that ursolic acid inhibited proliferation of Hut-78 cells(P<0.05).Apoptosis of Hut-78 cells was induced by 10,20,40 and 80 μmol/L ursolic acid treatment(P<0.01).Likewise,expressions of p65 and p50 proteins were down-regulated by ursolic acid treatment(10,20,40 and 80 μmol/L)(P<0.01),but there was no significant change in the expression of p52 and p100.Moreover,ursolic acid could up-regulate expression of caspase-8, caspase-3 and caspase-9 protein(P<0.01).RT-PCR examination showed that VEGF and COX-2 mRNA expression decreased by ursolic acid treatment.Conclusion Inhibition of Hut-78 cell proliferation may be related to ursolic acid induced apoptosis through h death receptors and mitochondrial pathways. NF-κB classical signal pathway may be one of its mechanisms,and VEGF and cox-2 may also be involved.

    (Authors)

    2015240 Retrospective efficacy analysis of decitabine bridging allogeneic hematopoietic stem cell transplantation on the treatment of myelodysplastic syndrome.ZHENG Huifei(鄭慧菲),et al.Instit Hematol,1st Affil Hosp,Soochow Univ,Suzhou 215006. Chin J Hematol 2015;36(2):121-124.

    Objective To evaluate the efficacy of decitabine (DAC)bridging therapy followed by allogeneic hematopoietic stem cell transplantation(allo-HSCT)in patients with myelodysplastic syndrome(MDS).Methods The clinical characteristics and curative effect of MDS patients who received allo-HSCT from 2010 July to 2013 December were retrospectively analyzed.Of them,25 MDS patients who received decitabine bridging allo-HSCT were randomly selected(referred to as the bridging group),while at the same time another 33 MDS patients who did not receive decitabine for allo-HSCT in MDS were also randomly selected as control group.The effect of decitabine bridging allo-HSCT on the patients'survival and occurrence of graft versus host disease(GVHD)was analyzed.ResultsWithdecitabinebridgetherapy,64.0%patients(16/25)achieved marrow complete remission before allo-HSCT,while the control group was only 15.1%(5/33,P<0.05).Decitabine bridging group of early transplant-related mortality was lower than that of the control group(4.0%vs 18.2%),but the difference was not statistically significant(P=0.106). Up to follow-up deadline,the mortality of decitabine bridging group was 12.0%,while that of the control group was 30.3%(P<0.05).The 2-year OS of decitabine bridging group was 83.0%,while that of the control group was 59.0%(P<0.05).Of the 14 patients in decitabine bridging group with aGVHD,7 was gradeⅠ aGVHD,3 gradeⅡand 4 gradeⅢ.Of the 16 patients in control group with aGVHD,7 was gradeⅠaGVHD,8 gradeⅡ and 1 gradeⅢ.Conclusion Decitabine bridging therapy followed by allo-HSCT in the treatment of MDS is safe and effective.

    (Authors)

    2015241 Analysis of blood cell autophagy distribution in hematologic diseases by transmission electron microscope.DONG Shuxu(董樹(shù)旭),et al.Instit Hematol&Blood Dis Hosp,CAMS&PUMC,Tianjin 300020.Chin J Hematol 2015;36(2):144-147.

    Objective To investigate the distribution characteristics of blood cells autophagy in hematologic diseases,as well as their possible pathomechanism.Methods Retrospective analysis of electron microscopy specimens of 3 277 patients with hematological diseases were performed. The blood cells autophagy was observed by transmission electron microscopy,and its distribution characteristics were analyzed.The pathomechanism of blood cell autophagy was explored in combination with clinical examination and diagnosis.Results 15 samples were found to have mature granulocytes or nucleated erythrocytes autophagy.Of them,6 cases were myelodysplastic syndrome (MDS),2 acute leukemia,1 in each of aplastic anemia,pure red cell aplastic anemia,thalassemia,iron deficiency anemia,lymphoma,multiple myeloma and polycythemia vera.Among 15 cases,11 cases were found to have mature granulocytes autophagy,4 cases nucleated erythrocytes autophagy.Besides autophagy,apoptosis occurred in 9 cases,cytolysis in 6 cases,megaloblastic change in 5 cases.Conclusion Mature granulocytes or nucleated erythrocytes autophagy occurred more frequently in MDS among hematologic diseases,dyshaematopoiesisincludingapoptosis,cytolysisandmegaloblastic change could induce autophagy function enhancement.

    (Authors)

    2015242 Gene analysis in a family of hereditary hemorrhagic telangiectasia.YUAN Dong(袁冬),et al.Mudanjian 1st People's Hosp,Mudanjiang 157011. Chin J Hematol 2015;36(2):

    112-115.

    Objective To investigate the clinical feature of a familywithhereditaryhemorrhagictelangiectasia (HHT),and to study the mutation of its related genes. Methods Medical histories of the family were analyzed to detect HHT patients according to the diagnostic criteria. ENG and ALK-1 genes of the proband and her two daughters were analyzed.DNA from the three patients' peripheral blood was extracted.The exons 2-10 and their intron-exon boundaries of ALK1 were amplified with PCR,and then the PCR products were sequenced and analyzed to identify the mutation.Results 11 people in 41 family members of 4 generations were diagnosed as HHT.The proband and her two daughters suffered from multiple organ damage,the younger daughter appeared only imaging features instead of corresponding clinical symptoms.A missense mutation at the 1321 bp of cDNA (c.1321G>A)was detected in the exon 9 of ALK1,which resulted in valine 441 to methionine replacement in ALK-1 protein(p.Va1441Met).Conclusion A Chinese family with HHT was studied and a missense mutation(c.1321G>A,p.Va1441Met)of ALK-1 was discovered.This mutation is the genetic basis of the family with HHT and is reported for the first time in China. This research will not only help to further investigate molecular mechanism of pathogenesis of HTT,but also provide evidence and references for the following gene screening and genetic counseling on HTT family members.

    (Authors)

    2015243 A single-center clinical study of 22 patients with acquired hemophilia.YANG Chunchen(楊春晨),et al.1st Affil Hosp,Soochow Univ,Suzhou 215006.Chin J Hematol 2015;36(2):107-111.

    Objective To investigate the feature of underlying disorders,clinical symptoms,diagnosis and treatment strategies of patients with acquired hemophilia(AH). Methods The clinical data and laboratory test results of 22 patients with AH from March 2010 to June 2014 were retrospectively analyzed.Results A total of 22 patients with AH were enrolled in our study,including 20 patients diagnosed as acquired hemophilia A(AHA)and 2 as acquired hemophilia B(AHB).Among the AHA patients,there were 10 males and 10 females with the median age of 37.5(range,2-95)years old.The median activity of FⅧ(FⅧ:C)of the 20 AHA patients was 1.9% (0.5%-39.0%).Softtissuehematoma (80.0%)and subcutaneous bleeding(75.0%)were the most common clinical symptoms.Two male children were diagnosed as AHB(age 1 and 3 years old,respectively)with mild bleeding symptoms,and the activities of FⅨ(FⅨ:C)were 5.0%and 16.0%,respectively.In addition,an underlying disorder was found in 7 patients (31.8%).In laboratory testing,all patients had prolonged APTT,normal PT,decreased FⅧ:C or FⅨ:C,positive antibody screening test or antibody titer(2-32 BU),and negative for lupus anticoagulant and anticardiolipin antibody.Nineteen out of 20 patients were treated with blood products to stop acute bleeding episodes.Corticosteroid alone was applied to 7 patients,corticosteroid combined with other immunosuppressive agents to 11 patients,rituximab to 3 patients.Nineteen patients responded well to hemostatic treatment,except 1 patient who died of fatal bleeding.The FⅧ:C of 8 patients increased to a normal level with the median time of 42.5(21-145)days.After treatment,the activity of FⅨ:C of the 2 AHB patients achieved 35%and 24%in 48 and 60 days,respectively.Conclusion Acquired hemophilia is not an uncommon disease in clinical practice,which may occur in people of all ages.AH is a bleeding disorder with heterogeneous characteristics.Compared with adult,the clinical symptoms of children patients were mild,which leads to underdiagnosis.

    (Authors)

    2015244 A multicenter clinical trial of caffeic acid tablet in treatment of 103 primary immune thrombocytopenia patients.QIN Ping(秦平),et al.Dept Hematol,Qilu Hosp,Shandong Univ,Jinan 250012.Chin J Hematol 2015;36(2):103-106.

    Objective To determine the efficacy and safety of oral caffeic acid(CA)tablet in management of primary immune thrombocytopenia(ITP).Methods One hundred and three ITP patients with PLT>10×109/L and no serious bleeding symptoms from three centers were enrolled.According to their platelet count before CA treatment,these patients were divided into group A(PLT<30×109/L),including 24 females and 27 males with median age 48(18-84)years;and group B(PLT≥30×109/L),including 33 females and 19 males with median age 43(18-83)years.Patients in both groups took CA tablets orally of 300 mg three times per day for 12 consecutive weeks.Combined medicine treatment such as corticosteroids,danazol,TPO and Rituximab,which might increase the platelet count of these patients,were not allowed during CA therapy.Results In group A,the overall response rate was 51.0%(26/51),with 2 patients achieving complete response(CR)and 24 patients achieving response(R).Of 26 patients achieving response(CR+R),the median platelet count before CA therapy was 20.5(15-28)×109/L,and the median peak platelet count after CA therapy was 63(38-112)× 109/L.The median time to achieve response was 4 (2-10)weeks.Patients with pretreatment PLT>20× 109/L showed significantly better response than those PLT<20×109/L(68.0%vs 34.6%,P=0.017).In group B,the CR rate was 40.4%(21/52).Frequency of CA-related adverse events was 1.94%(2/103),including mild nausea in 1 case and elevation of liver enzymes in 1 case.Both were grade 1 and transient.Conclusion Caffeic acid was effective in patients with ITP with few and mild adverse effects.

    (Authors)

    2015245 Effectofimmunoglobulinheavy/light chain detection on the minimal residual disease monitoring in IgG multiple myeloma patients.ZHANG Hui(張慧),et al.Dept Hematol,Changzheng Hosp,2nd Milit Med Univ,Shanghai 200003.Chin J Hematol 2015;36(2):95-98.

    Objective To evaluate the specificity and sensitivity of immunoglobulin heavy/light chain(HLC)and serum free light chain(FLC)level in minimal residual disease monitoring of IgG type multiple myeloma(MM)patients during complete remission(CR).Methods Immunoglobulin HLC was assessed in 20 IgG myeloma patients by immune turbidimetry using SPAplus Analyzer.The serum level of HLC and FLC was detected at the same time. Combined with those obtained by serum protein electrophoresis(SPE)and immune fixation electrophoresis (IFE),the specificity and sensitivity of HLC in detection of serum immunoglobulin were analyzed.Combined with the clinical efficacy,kappa/lambda ratios of HLC (rHLC)and FLC(rFLC)were compared between the patients and normal controls.Results Among 20 patients,there were 10 male and 10 female,the median age was 56 years(35-70).There were 6 patients with abnormal rHLC but normal rFLC;3 patients with abnormal rFLC but normal HLC;and 11 patients with both normal rHLC and rFLC.During the mean follow-up time of 18 months,4 of the 6 patients with abnormal rHLC accepted intervention therapies,1 case relapsed in 9 months,the other 2 untreated patients relapsed in 3 months.Among the 3 cases with abnormal rFLC,2 patients are still in remission after intervention therapies,the other untreated patient relapsed in 1.5 months.A-mong the 11 untreated patients with both normal rHLC and rFLC,3 relapsed with the disease free survival time of 3.5 months,5.0 months and 5.5 months respectively.Conclusion The combined detection of HLC and FLC is helpful to assess the curative efficacy and the accuracy of minimal residual disease monitoring,and more effectively evaluate the prognosis of MM patients.Abnormal rHLC and rFLC are correlated with poor prognosis,while early intervention therapies can help to improve disease free survival.

    (Authors)

    2015246 The relationship between induction chemotherapy cycles and prognosis in patients with acute myeloid leukemia.ZHAO Ting(趙婷),et al.Peking Univ People's Hosp,Beijing 100044.Chin J Hematol 2015;36(2):89-94.

    Objective To explore the relationship between induction chemotherapy cycles to achieve complete remission(CR)and prognosis in patients with acute myeloid leukemia(AML).Methods From April 2004 to December 2013,397 adult patients with newly diagnosed AML (acute promyelocytic leukemia excluded)received the idarubicin combined with cytarabine(IA)“3+7”regimen as the first induction chemotherapy were enrolled in the study.Therapeutic effect,relapse and survival of these patients were discussed.Patients underwent continuous consolidation chemotherapy,and some eligible patients received allogeneic hematopoietic st em cell trans-plantation(allo-HSCT)in the first complete remission. Results Of 397 patients,347 valuable patients achieved CR after 1-4 cycles induction chemotherapy.The median follow-up was 18.0(2.4-115.4)months in survivors,the cumulative incidence of relapse(CIR),disease-free survival(DFS)and overall survival(OS)at 3 years were 33.0%,58.6%and 67.1%,respectively. Multivariate analysis revealed that unfavorable cytogenetics,more cycles to achieve CR and post-remission treatment without allo-HSCT were independent risk factors affecting DFS and OS.FLT3-ITD mutation positive was another independent risk factor affecting DFS.There was no statistic difference between patients who achieved CR after one cycle(n=255)and two cycles(n=73)treatment in DFS and OS(P>0.05).DFS and OS in patients who achieved CR after 3 or 4 cycles(n=19)were significantly lower than the above two groups(P<0.05).Multivariate analysis among 183 patients who received consistent chemotherapy showed that achieving CR within 2 cycles was the favorable factor affecting DFS and OS(P=0.001,P=0.035).Conclusion Achieving CR within 2 cycles of induction chemotherapy was associated with better prognosis among adult CR patients with AML.

    (Authors)

    猜你喜歡
    楊力
    一次“探險(xiǎn)”帶來(lái)的思考
    他的“左手”
    父女鐵索飛渡,綻放在懸崖上的“死亡舞蹈”
    星期一
    西部(2021年1期)2021-03-02 01:07:31
    心理扭曲的“激情”犯罪
    楊力:孤獨(dú)者住在大世界
    商周刊(2019年14期)2019-09-16 04:29:00
    楊力:徜徉在中華民族傳統(tǒng)文化的海洋里
    任性的好醫(yī)生
    做人與處世(2019年1期)2019-02-25 05:23:22
    楊力:我的文史哲醫(yī)夢(mèng)
    “40后”眼中的幸福經(jīng)濟(jì)學(xué)
    小康(2016年21期)2016-11-09 14:10:48
    日韩大码丰满熟妇| av网站免费在线观看视频| 在线观看人妻少妇| 国产片特级美女逼逼视频| 天堂8中文在线网| 亚洲国产中文字幕在线视频| 欧美中文综合在线视频| 丰满人妻熟妇乱又伦精品不卡| www.熟女人妻精品国产| 欧美人与性动交α欧美精品济南到| 大话2 男鬼变身卡| 午夜福利在线免费观看网站| 国产在线视频一区二区| 大陆偷拍与自拍| 91精品三级在线观看| 18禁国产床啪视频网站| 亚洲精品久久成人aⅴ小说| 一区福利在线观看| 两个人免费观看高清视频| 日韩熟女老妇一区二区性免费视频| 日本五十路高清| 51午夜福利影视在线观看| 91麻豆精品激情在线观看国产 | 乱人伦中国视频| av在线播放精品| 国产1区2区3区精品| 99国产精品99久久久久| 中文乱码字字幕精品一区二区三区| 国产1区2区3区精品| 人妻人人澡人人爽人人| 少妇猛男粗大的猛烈进出视频| 一边亲一边摸免费视频| 香蕉国产在线看| 国产欧美日韩精品亚洲av| 丝袜在线中文字幕| 国产成人免费无遮挡视频| 激情五月婷婷亚洲| 少妇人妻久久综合中文| 自拍欧美九色日韩亚洲蝌蚪91| 国产精品免费大片| 日韩av免费高清视频| 国产麻豆69| 自拍欧美九色日韩亚洲蝌蚪91| 成人影院久久| 亚洲欧洲国产日韩| 国产极品粉嫩免费观看在线| 精品欧美一区二区三区在线| 欧美中文综合在线视频| 看免费av毛片| 丰满迷人的少妇在线观看| 制服人妻中文乱码| 一本大道久久a久久精品| 国产精品一区二区精品视频观看| 国产精品 欧美亚洲| 免费一级毛片在线播放高清视频 | 亚洲,一卡二卡三卡| 夜夜骑夜夜射夜夜干| 国产精品久久久久成人av| 晚上一个人看的免费电影| 男人添女人高潮全过程视频| tube8黄色片| 欧美日韩亚洲高清精品| 亚洲一卡2卡3卡4卡5卡精品中文| 大香蕉久久成人网| 久久精品亚洲av国产电影网| 最黄视频免费看| 极品人妻少妇av视频| 777米奇影视久久| 日本猛色少妇xxxxx猛交久久| 久久热在线av| 日本av手机在线免费观看| 久久精品久久精品一区二区三区| 精品少妇内射三级| 免费在线观看视频国产中文字幕亚洲 | 国产一区有黄有色的免费视频| 午夜福利一区二区在线看| 国产欧美日韩精品亚洲av| 欧美激情高清一区二区三区| 伊人亚洲综合成人网| 亚洲伊人久久精品综合| 我的亚洲天堂| 丝袜脚勾引网站| 亚洲专区中文字幕在线| 色婷婷久久久亚洲欧美| 汤姆久久久久久久影院中文字幕| 国产精品久久久av美女十八| 狠狠精品人妻久久久久久综合| av在线老鸭窝| 国产精品久久久人人做人人爽| 在线精品无人区一区二区三| 麻豆av在线久日| tube8黄色片| 国产成人啪精品午夜网站| 亚洲国产最新在线播放| 秋霞在线观看毛片| 精品亚洲成a人片在线观看| 久久精品aⅴ一区二区三区四区| 成人亚洲欧美一区二区av| 天天添夜夜摸| 免费观看人在逋| 日韩制服骚丝袜av| 激情五月婷婷亚洲| 国产片特级美女逼逼视频| 久久久国产欧美日韩av| 久久久欧美国产精品| 免费女性裸体啪啪无遮挡网站| 99热国产这里只有精品6| 国产激情久久老熟女| 脱女人内裤的视频| av不卡在线播放| 国产在线一区二区三区精| videos熟女内射| 90打野战视频偷拍视频| 别揉我奶头~嗯~啊~动态视频 | 国产97色在线日韩免费| 日日摸夜夜添夜夜爱| 国产精品一二三区在线看| 久久狼人影院| 99精国产麻豆久久婷婷| 99国产精品一区二区蜜桃av | 久久久久视频综合| 国产视频首页在线观看| 9热在线视频观看99| 精品亚洲成国产av| 啦啦啦 在线观看视频| 男女免费视频国产| xxx大片免费视频| 人人妻人人澡人人看| 欧美久久黑人一区二区| 我要看黄色一级片免费的| 国产一区有黄有色的免费视频| 亚洲欧美精品自产自拍| 视频区图区小说| 国产成人免费观看mmmm| 久久国产亚洲av麻豆专区| 国产黄色视频一区二区在线观看| 亚洲少妇的诱惑av| 99精国产麻豆久久婷婷| 一区在线观看完整版| 高潮久久久久久久久久久不卡| 激情视频va一区二区三区| 在线观看人妻少妇| 欧美日韩亚洲综合一区二区三区_| 两人在一起打扑克的视频| 熟女少妇亚洲综合色aaa.| 人妻人人澡人人爽人人| 精品亚洲乱码少妇综合久久| 十八禁网站网址无遮挡| 中文字幕人妻丝袜制服| 首页视频小说图片口味搜索 | 色94色欧美一区二区| 久久精品成人免费网站| 欧美国产精品一级二级三级| 国产亚洲av高清不卡| 宅男免费午夜| 国产成人影院久久av| 制服人妻中文乱码| 国产片特级美女逼逼视频| 欧美av亚洲av综合av国产av| 一级毛片黄色毛片免费观看视频| 欧美日韩福利视频一区二区| 精品少妇久久久久久888优播| 国产高清视频在线播放一区 | 亚洲 国产 在线| av视频免费观看在线观看| 亚洲av日韩精品久久久久久密 | 激情五月婷婷亚洲| 丝袜脚勾引网站| 国产主播在线观看一区二区 | 欧美乱码精品一区二区三区| 每晚都被弄得嗷嗷叫到高潮| 午夜福利,免费看| 黑人猛操日本美女一级片| 国产成人免费观看mmmm| 婷婷丁香在线五月| 亚洲av电影在线观看一区二区三区| 欧美日韩av久久| 亚洲成人国产一区在线观看 | 满18在线观看网站| 青草久久国产| 激情五月婷婷亚洲| 啦啦啦在线免费观看视频4| 国语对白做爰xxxⅹ性视频网站| 蜜桃国产av成人99| 丝袜喷水一区| 国产亚洲欧美在线一区二区| 男女边摸边吃奶| 亚洲一卡2卡3卡4卡5卡精品中文| 久久影院123| 国产老妇伦熟女老妇高清| 亚洲精品国产av蜜桃| 久久久国产欧美日韩av| 久久精品国产亚洲av涩爱| 国产又色又爽无遮挡免| 国产精品二区激情视频| 久久天躁狠狠躁夜夜2o2o | 国产精品免费视频内射| 国产亚洲精品第一综合不卡| 国产免费一区二区三区四区乱码| 下体分泌物呈黄色| 亚洲国产成人一精品久久久| 国产精品一区二区精品视频观看| 久久精品熟女亚洲av麻豆精品| 在线看a的网站| 女人精品久久久久毛片| 国精品久久久久久国模美| 黄色 视频免费看| 亚洲,欧美,日韩| 亚洲五月婷婷丁香| 男女边吃奶边做爰视频| 99国产精品99久久久久| 亚洲av在线观看美女高潮| 19禁男女啪啪无遮挡网站| 亚洲伊人久久精品综合| 91九色精品人成在线观看| 国产xxxxx性猛交| 久久毛片免费看一区二区三区| a级片在线免费高清观看视频| 男女下面插进去视频免费观看| 自拍欧美九色日韩亚洲蝌蚪91| 亚洲午夜精品一区,二区,三区| 美女中出高潮动态图| 国产精品av久久久久免费| 亚洲一卡2卡3卡4卡5卡精品中文| 国产av国产精品国产| 精品国产超薄肉色丝袜足j| 亚洲专区国产一区二区| 免费黄频网站在线观看国产| 日本黄色日本黄色录像| 大香蕉久久网| 性色av一级| 国产高清视频在线播放一区 | 真人做人爱边吃奶动态| 亚洲自偷自拍图片 自拍| 亚洲国产精品国产精品| 成人亚洲欧美一区二区av| 婷婷色综合大香蕉| 啦啦啦中文免费视频观看日本| 老司机靠b影院| 性高湖久久久久久久久免费观看| 一区二区av电影网| av电影中文网址| 波多野结衣av一区二区av| 国产熟女欧美一区二区| 国产精品亚洲av一区麻豆| 一边摸一边抽搐一进一出视频| 亚洲欧美色中文字幕在线| cao死你这个sao货| 久久影院123| www.自偷自拍.com| 国产色视频综合| 美女国产高潮福利片在线看| 亚洲av日韩精品久久久久久密 | 亚洲第一av免费看| 午夜老司机福利片| 国产一级毛片在线| 丝袜人妻中文字幕| 久久精品亚洲熟妇少妇任你| 国产熟女欧美一区二区| 精品国产国语对白av| 欧美黄色片欧美黄色片| 欧美国产精品一级二级三级| 精品一区二区三卡| 色婷婷av一区二区三区视频| 飞空精品影院首页| 后天国语完整版免费观看| 一级毛片我不卡| 亚洲久久久国产精品| 高清av免费在线| 99久久人妻综合| a级毛片在线看网站| 精品卡一卡二卡四卡免费| 亚洲成人国产一区在线观看 | 十八禁高潮呻吟视频| 国产精品成人在线| 97精品久久久久久久久久精品| 狠狠婷婷综合久久久久久88av| 色视频在线一区二区三区| 久久久精品免费免费高清| 99热网站在线观看| 91字幕亚洲| 亚洲精品久久久久久婷婷小说| 午夜福利影视在线免费观看| 色94色欧美一区二区| 黄色怎么调成土黄色| 考比视频在线观看| 黑人猛操日本美女一级片| 午夜影院在线不卡| 可以免费在线观看a视频的电影网站| 久久久久久久大尺度免费视频| 久久久国产精品麻豆| 99热网站在线观看| 亚洲色图综合在线观看| 搡老乐熟女国产| 999精品在线视频| 深夜精品福利| 日本色播在线视频| 精品卡一卡二卡四卡免费| 亚洲少妇的诱惑av| 视频在线观看一区二区三区| 高清不卡的av网站| 国产日韩欧美亚洲二区| 亚洲一区二区三区欧美精品| 色视频在线一区二区三区| 久久狼人影院| 制服诱惑二区| 免费在线观看视频国产中文字幕亚洲 | 一区二区三区精品91| 欧美久久黑人一区二区| 亚洲国产成人一精品久久久| 51午夜福利影视在线观看| 男女高潮啪啪啪动态图| 欧美亚洲日本最大视频资源| 啦啦啦 在线观看视频| 亚洲精品自拍成人| 精品久久蜜臀av无| 午夜激情av网站| 色网站视频免费| av一本久久久久| 午夜精品国产一区二区电影| 亚洲av国产av综合av卡| 亚洲精品av麻豆狂野| 国产xxxxx性猛交| 亚洲美女黄色视频免费看| 激情五月婷婷亚洲| 男人舔女人的私密视频| 日韩人妻精品一区2区三区| 国产精品欧美亚洲77777| 中国国产av一级| 999久久久国产精品视频| 欧美在线黄色| 国产成人精品在线电影| 丝袜人妻中文字幕| 午夜激情久久久久久久| 咕卡用的链子| 亚洲第一青青草原| 菩萨蛮人人尽说江南好唐韦庄| 国产在视频线精品| 成人午夜精彩视频在线观看| 久久免费观看电影| 欧美日韩一级在线毛片| av片东京热男人的天堂| 国产97色在线日韩免费| 啦啦啦在线观看免费高清www| 国产精品三级大全| 国产激情久久老熟女| 亚洲精品国产色婷婷电影| 亚洲情色 制服丝袜| 夫妻午夜视频| 成人影院久久| 精品一区二区三区av网在线观看 | av网站在线播放免费| 久久久国产一区二区| 一级黄色大片毛片| 夫妻性生交免费视频一级片| 又大又黄又爽视频免费| 国产欧美亚洲国产| 少妇人妻久久综合中文| 少妇 在线观看| av有码第一页| 老司机午夜十八禁免费视频| 在线观看免费高清a一片| 欧美亚洲日本最大视频资源| 夫妻性生交免费视频一级片| 大片电影免费在线观看免费| 美国免费a级毛片| tube8黄色片| 视频在线观看一区二区三区| 亚洲成人手机| 国产精品香港三级国产av潘金莲 | 免费一级毛片在线播放高清视频 | 纵有疾风起免费观看全集完整版| 精品第一国产精品| 日韩制服丝袜自拍偷拍| 亚洲精品自拍成人| 真人做人爱边吃奶动态| 午夜福利乱码中文字幕| 最黄视频免费看| 9热在线视频观看99| 丝袜美腿诱惑在线| 国产免费一区二区三区四区乱码| 国产精品一区二区在线观看99| 亚洲精品av麻豆狂野| 亚洲国产日韩一区二区| 亚洲精品av麻豆狂野| videosex国产| 91精品伊人久久大香线蕉| 女性生殖器流出的白浆| 一本久久精品| 国产伦人伦偷精品视频| 国产精品熟女久久久久浪| 国产免费福利视频在线观看| 2021少妇久久久久久久久久久| 国产有黄有色有爽视频| 色婷婷久久久亚洲欧美| 亚洲黑人精品在线| 久热爱精品视频在线9| 免费高清在线观看视频在线观看| 性色av一级| 只有这里有精品99| 欧美 日韩 精品 国产| 99精品久久久久人妻精品| 亚洲精品在线美女| 国产色视频综合| 欧美日韩亚洲高清精品| 中文字幕人妻熟女乱码| 纯流量卡能插随身wifi吗| 亚洲国产av新网站| av天堂在线播放| 女人精品久久久久毛片| 亚洲精品久久成人aⅴ小说| 国产精品 欧美亚洲| 国产又色又爽无遮挡免| 亚洲色图综合在线观看| 国产男女超爽视频在线观看| 老司机深夜福利视频在线观看 | 欧美少妇被猛烈插入视频| 热99久久久久精品小说推荐| 色视频在线一区二区三区| av有码第一页| 国产在视频线精品| 亚洲av欧美aⅴ国产| 秋霞在线观看毛片| 亚洲天堂av无毛| 亚洲专区中文字幕在线| 菩萨蛮人人尽说江南好唐韦庄| 极品少妇高潮喷水抽搐| 自拍欧美九色日韩亚洲蝌蚪91| 80岁老熟妇乱子伦牲交| 久久综合国产亚洲精品| 美女高潮到喷水免费观看| 热re99久久国产66热| 午夜福利在线免费观看网站| 婷婷色综合www| 亚洲国产精品一区二区三区在线| 国产精品一区二区精品视频观看| 香蕉国产在线看| 嫩草影视91久久| 亚洲免费av在线视频| 久久精品熟女亚洲av麻豆精品| 一级毛片电影观看| 日韩,欧美,国产一区二区三区| 高潮久久久久久久久久久不卡| videosex国产| 亚洲精品国产av成人精品| 美女高潮到喷水免费观看| 99精品久久久久人妻精品| 欧美日韩av久久| 最新的欧美精品一区二区| 超碰97精品在线观看| 日韩伦理黄色片| 十八禁高潮呻吟视频| 日韩av免费高清视频| 80岁老熟妇乱子伦牲交| 高潮久久久久久久久久久不卡| 女人久久www免费人成看片| 99国产精品99久久久久| 国产有黄有色有爽视频| 不卡av一区二区三区| 免费女性裸体啪啪无遮挡网站| 五月天丁香电影| 老鸭窝网址在线观看| 99热全是精品| 亚洲一卡2卡3卡4卡5卡精品中文| 亚洲国产毛片av蜜桃av| 美女扒开内裤让男人捅视频| 一本一本久久a久久精品综合妖精| 少妇猛男粗大的猛烈进出视频| 老司机影院毛片| 亚洲自偷自拍图片 自拍| 免费看十八禁软件| 老司机靠b影院| 国产一区二区在线观看av| 日韩电影二区| 久久国产精品人妻蜜桃| 亚洲人成电影观看| 久久久久久人人人人人| 久久这里只有精品19| 亚洲国产看品久久| 久久国产精品人妻蜜桃| 色网站视频免费| www日本在线高清视频| 国产精品 国内视频| 国产成人欧美| 亚洲欧美成人综合另类久久久| 91成人精品电影| 国产片内射在线| www.999成人在线观看| 国产成人免费无遮挡视频| 老司机影院毛片| 手机成人av网站| 麻豆国产av国片精品| 亚洲av成人不卡在线观看播放网 | 国产精品免费大片| 精品人妻熟女毛片av久久网站| 我的亚洲天堂| 一本一本久久a久久精品综合妖精| 国产成人av激情在线播放| 五月开心婷婷网| 亚洲午夜精品一区,二区,三区| 青草久久国产| tube8黄色片| 久久ye,这里只有精品| 久久久国产精品麻豆| 女性被躁到高潮视频| 欧美日韩视频精品一区| 久久久国产欧美日韩av| 9色porny在线观看| 90打野战视频偷拍视频| 一级a爱视频在线免费观看| 欧美人与性动交α欧美精品济南到| 国产日韩欧美亚洲二区| 精品一区在线观看国产| 国产男女超爽视频在线观看| 亚洲欧美精品综合一区二区三区| 少妇人妻 视频| 国产成人系列免费观看| 激情五月婷婷亚洲| 久久久国产精品麻豆| 五月天丁香电影| 亚洲美女黄色视频免费看| 丝袜喷水一区| 欧美精品av麻豆av| 国产精品.久久久| 丰满少妇做爰视频| 久久免费观看电影| 人人妻,人人澡人人爽秒播 | 丁香六月天网| 亚洲国产欧美在线一区| 国产欧美亚洲国产| 午夜激情av网站| 欧美日韩一级在线毛片| 国产主播在线观看一区二区 | 男女免费视频国产| 老汉色∧v一级毛片| 亚洲国产欧美在线一区| 黄色视频不卡| 一本综合久久免费| 如日韩欧美国产精品一区二区三区| 亚洲国产精品国产精品| 制服人妻中文乱码| 国产精品av久久久久免费| 日韩中文字幕欧美一区二区 | 国产一区有黄有色的免费视频| 丰满迷人的少妇在线观看| 十八禁网站网址无遮挡| 一本大道久久a久久精品| 久久99精品国语久久久| 好男人电影高清在线观看| 少妇的丰满在线观看| 波多野结衣av一区二区av| 丰满人妻熟妇乱又伦精品不卡| avwww免费| 国产精品免费大片| 天天躁狠狠躁夜夜躁狠狠躁| 午夜久久久在线观看| 考比视频在线观看| av国产精品久久久久影院| 国产亚洲精品久久久久5区| 女性被躁到高潮视频| 国产黄频视频在线观看| 伊人久久大香线蕉亚洲五| 国产成人一区二区三区免费视频网站 | 免费在线观看影片大全网站 | 久久久久久久精品精品| 日韩欧美一区视频在线观看| 国产精品 欧美亚洲| 久久久精品免费免费高清| 久久综合国产亚洲精品| 国产在线免费精品| 国产成人精品久久二区二区免费| videosex国产| 人妻人人澡人人爽人人| 国产成人精品久久二区二区91| 国产日韩欧美视频二区| 两性夫妻黄色片| 欧美成人精品欧美一级黄| 日韩制服骚丝袜av| 精品人妻一区二区三区麻豆| 中文精品一卡2卡3卡4更新| 日韩欧美一区视频在线观看| 黄片播放在线免费| 国产一区二区激情短视频 | 亚洲国产欧美网| 香蕉丝袜av| 下体分泌物呈黄色| 一区二区三区精品91| 亚洲专区中文字幕在线| 精品一区二区三区四区五区乱码 | 成在线人永久免费视频| 成年人午夜在线观看视频| 母亲3免费完整高清在线观看| 在线观看www视频免费| 女人精品久久久久毛片| 亚洲成av片中文字幕在线观看| www日本在线高清视频| 国产成人一区二区三区免费视频网站 | 欧美精品一区二区大全| www.自偷自拍.com| 国产精品三级大全| 国产高清不卡午夜福利| 老汉色∧v一级毛片| 自拍欧美九色日韩亚洲蝌蚪91| 久久久国产精品麻豆| 97精品久久久久久久久久精品| 亚洲精品乱久久久久久| 久久精品国产亚洲av涩爱| 一级a爱视频在线免费观看| 菩萨蛮人人尽说江南好唐韦庄| 91精品三级在线观看| 亚洲精品日本国产第一区| 少妇人妻久久综合中文| 欧美激情 高清一区二区三区| 国产片特级美女逼逼视频| 黄色片一级片一级黄色片|